Changes related to "Lee:Literature PK/PD/PGx"

From OpenWetWare
Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 10:08, 25 September 2017
   
Page name:

21 September 2017

     17:21  Lee:Research‎‎ (17 changes | history) . . (+6,105). . [Wooin Lee‎ (17×)]
      17:21 (cur | prev) . . (+86). . Wooin Lee (talk | contribs)
      17:20 (cur | prev) . . (+111). . Wooin Lee (talk | contribs)
      17:18 (cur | prev) . . (+47). . Wooin Lee (talk | contribs) (I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes)
      17:18 (cur | prev) . . (-91). . Wooin Lee (talk | contribs)
      17:16 (cur | prev) . . (+166). . Wooin Lee (talk | contribs) (I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes)
      09:22 (cur | prev) . . (-8). . Wooin Lee (talk | contribs)
      09:21 (cur | prev) . . (+212). . Wooin Lee (talk | contribs)
      09:16 (cur | prev) . . (+19). . Wooin Lee (talk | contribs) (II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities)
      09:10 (cur | prev) . . (+22). . Wooin Lee (talk | contribs) (I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes)
      09:07 (cur | prev) . . (+147). . Wooin Lee (talk | contribs) (III. Clinical Pharmacokinetics and Pharmacogenomics)
      09:02 (cur | prev) . . (+910). . Wooin Lee (talk | contribs) (III. Cancer Pharmacogenomics)
      08:53 (cur | prev) . . (+517). . Wooin Lee (talk | contribs) (II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities)
      08:50 (cur | prev) . . (+1,061). . Wooin Lee (talk | contribs) (II. Development of novel proteasome inhibitor drugs and delivery strategies to improve anticancer efficacy and expand therapeutic utilities)
      08:29 (cur | prev) . . (+269). . Wooin Lee (talk | contribs) (I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes)
      08:28 (cur | prev) . . (-5). . Wooin Lee (talk | contribs) (I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes)
      08:28 (cur | prev) . . (+1,206). . Wooin Lee (talk | contribs) (I. Investigation of the impact of splicing and other genetic variations on drug transporters and proteasomes)
      04:40 (cur | prev) . . (+1,436). . Wooin Lee (talk | contribs)
     08:55  Lee:Lab Members‎ (diff | hist) . . (+49). . Wooin Lee (talk | contribs) (Graduate students)